Advertisement
Advertisement
NEPH
Nephros Inc.
4.21
USDSponsored
+0.62
+17.27%
Aug 07, 15:48 UTC -4
Closed
After-Market
4.18
-0.03
-0.59%
NEPH Earnings Reports
Positive Surprise Ratio
NEPH beat 16 of 28 last estimates.
57%
Next Report
Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$5.52M
/$0.02
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q3 25 (Revenue/ EPS)
+15.77%
/-33.33%
Nephros Inc. earnings per share and revenue
On Aug 05, 2026, NEPH reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of 0.00 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 5.09 million, with a --% difference.
Looking ahead to Q3 26, 3 analysts forecast an EPS of 0.02 USD, with revenue projected to reach 5.52 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
United-Guardian, Inc.
Report Date
Aug 07, 2026 For Q2 26
Estimate
-Actual
$0.16
Surprise
-
Cytosorbents Corp.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
ResMed Inc.
Report Date
Aug 06, 2026 For Q4 26
Estimate
$2.91
Actual
$2.95
Surprise
+1.09%
Lantheus Holdings, Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.31
Actual
$1.55
Surprise
+17.50%
ICU Medical Inc
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.95
Actual
$2.37
Surprise
+21.43%
Haemonetics Corporation
Report Date
Aug 06, 2026 For Q1 27
Estimate
$1.08
Actual
$1.13
Surprise
+4.82%
Prestige Consumer Healthcare Inc.
Report Date
Aug 06, 2026 For Q1 27
Estimate
$0.89
Actual
$0.98
Surprise
+10.01%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.04
Actual
-$0.02
Surprise
+54.65%
BioLife Solutions Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.03
Actual
$0.04
Surprise
+17.65%
Canopy Growth Corporation Common Shares
Report Date
Aug 07, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.02
Surprise
+75.74%
FAQ
What were Nephros Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Nephros Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Nephros Inc.'s Q2 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Nephros Inc. expected to report next?
The next earning report is scheduled for Nov 04, 2026.
What are the forecasts for Nephros Inc.'s next earnings report?
Based on 3
analysts, Nephros Inc. is expected to report EPS of $0.02 and revenue of $5.52M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement